PT1165491E - Inibidores da lta4 hidrolase - Google Patents

Inibidores da lta4 hidrolase

Info

Publication number
PT1165491E
PT1165491E PT00917145T PT00917145T PT1165491E PT 1165491 E PT1165491 E PT 1165491E PT 00917145 T PT00917145 T PT 00917145T PT 00917145 T PT00917145 T PT 00917145T PT 1165491 E PT1165491 E PT 1165491E
Authority
PT
Portugal
Prior art keywords
sub
compounds
hydrolase inhibitors
lta4 hydrolase
relates
Prior art date
Application number
PT00917145T
Other languages
English (en)
Inventor
Jeanne-Marie Lecomte
Lucette Duhamel
Pierre Duhamel
Jean-Charles Schwartz
Thierry Monteil
Jean-Christophe Plaquevent
Serge Piettre
Denis Danvy
Nadine Noel
Claude Gros
Olivier Chamard
Original Assignee
Bioprojet Soc Civ
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet Soc Civ, Inst Nat Sante Rech Med filed Critical Bioprojet Soc Civ
Publication of PT1165491E publication Critical patent/PT1165491E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00917145T 1999-04-06 2000-04-06 Inibidores da lta4 hidrolase PT1165491E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9904271A FR2791982B1 (fr) 1999-04-06 1999-04-06 Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques.

Publications (1)

Publication Number Publication Date
PT1165491E true PT1165491E (pt) 2004-06-30

Family

ID=9544064

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00917145T PT1165491E (pt) 1999-04-06 2000-04-06 Inibidores da lta4 hidrolase

Country Status (12)

Country Link
US (2) US6878723B1 (pt)
EP (1) EP1165491B1 (pt)
JP (1) JP2003506317A (pt)
KR (1) KR100801779B1 (pt)
AT (1) ATE259348T1 (pt)
CA (1) CA2368493A1 (pt)
DE (1) DE60008222T2 (pt)
DK (1) DK1165491T3 (pt)
ES (1) ES2218143T3 (pt)
FR (1) FR2791982B1 (pt)
PT (1) PT1165491E (pt)
WO (1) WO2000059864A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NI200300043A (es) 2002-03-28 2003-11-05 Warner Lambert Co AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
US7851486B2 (en) 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
US7507531B2 (en) 2002-10-17 2009-03-24 Decode Genetics Chf. Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
RU2344121C2 (ru) * 2003-09-25 2009-01-20 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си Способы лечения заболеваний у млекопитающих
CN101166524B (zh) 2005-04-28 2010-12-22 辉瑞有限公司 氨基酸衍生物
AU2009276343A1 (en) * 2008-08-01 2010-02-04 Bioxiness Pharmaceuticals, Inc. Methionine analogs and methods of using same
CA2912747C (en) 2013-06-27 2021-05-04 Lg Life Sciences Ltd. Biaryl derivatives as gpr120 agonists
MX2017007874A (es) 2014-12-24 2018-01-24 Lg Chemical Ltd Derivado de biarilo como agonista de gpr120.
CN104872161A (zh) * 2015-05-04 2015-09-02 桂林桂开生物科技股份有限公司 复合型植物生长调节剂及其制备方法
JP7174700B2 (ja) * 2016-12-09 2022-11-17 セルタクシー、エルエルシー ロイコトリエンａ４ヒドロラーゼの阻害剤としてのモノアミン及びモノアミン誘導体

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475193A (de) * 1966-06-07 1969-07-15 Hoffmann La Roche Verfahren zur Herstellung von Phenylalaninderivaten
US4071552A (en) * 1976-05-19 1978-01-31 Ayerst Mckenna And Harrison Ltd. Aryloxy aminobutanols, their preparation and use thereof
US4341767A (en) * 1980-10-06 1982-07-27 Syntex Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US5455271A (en) * 1992-06-18 1995-10-03 The Scripps Research Institute Tight-binding inhibitors of leukotriene A4 hydrolase
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
US5362899A (en) * 1993-09-09 1994-11-08 Affymax Technologies, N.V. Chiral synthesis of alpha-aminophosponic acids
US5508463A (en) * 1994-03-17 1996-04-16 Trustees Of The University Of Pennsylvania α-aminophosphonates
ATE361909T1 (de) * 1996-10-23 2007-06-15 Warner Lambert Co Substituierte gamma-aminobuttersäurederivate als arzneimittel
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors

Also Published As

Publication number Publication date
ES2218143T3 (es) 2004-11-16
FR2791982A1 (fr) 2000-10-13
DE60008222D1 (de) 2004-03-18
EP1165491A1 (fr) 2002-01-02
WO2000059864A1 (fr) 2000-10-12
FR2791982B1 (fr) 2002-12-27
DE60008222T2 (de) 2004-12-02
EP1165491B1 (fr) 2004-02-11
JP2003506317A (ja) 2003-02-18
KR100801779B1 (ko) 2008-02-05
DK1165491T3 (da) 2004-06-14
US7094773B2 (en) 2006-08-22
CA2368493A1 (fr) 2000-10-12
ATE259348T1 (de) 2004-02-15
US6878723B1 (en) 2005-04-12
KR20010108437A (ko) 2001-12-07
US20050027013A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
MXPA03011681A (es) Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular.
BR9908280A (pt) Inibidores de enzimas de fosfolipase
AU4180900A (en) Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase
BR0212510A (pt) Inibidor de histona desacetilase, composto e composição
PT966465E (pt) Inibidores do enzima imfdh
NO20023786D0 (no) Heteroaromatiske karboksamidderivater og deres anvendelse som inhibitorer av enzymet IKK-2
WO2002058690A3 (en) Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
NO20062092L (no) Nye fremgangsmater for fremstilling av N-desmetylzopiklon og optisk rent (+)-N-desmetylzopiklon og optisk rent (-)-N-desmetylzopiklon
CA2367017A1 (en) Inhibitors of impdh enzyme
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
NO20041379L (no) Enzymatiske prosesser for fremstilling av 4-substituerte 3-hydroksysmorsyrederivater
AU6894800A (en) Caspase inhibitors and uses thereof
PT1165491E (pt) Inibidores da lta4 hidrolase
BR0010119A (pt) Composição para prevenir ou tratar da demência contendo um derivado do ácido hidroxicinâmico ou um extrato de uma planta do genus angelicae contendo o mesmo
AU1185801A (en) Novel compounds
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
NO20025015D0 (no) Et pyridin-1-oksidderivat, og fremgangsmåte for dets overföring til farmasöytisk effektive forbindelser
WO2001091796A8 (en) Methods, compounds and compositions for treating gout
BR0109328A (pt) Inibidores de metaloprotease n-substituìdos, contendo cadeia lateral heterocìclica
HK1075663A1 (en) Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a sb 2 /sb
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
IL172134A0 (en) Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
AU5999798A (en) Heterocyclic compounds useful as oxido-squalene cyclase inhibitors